Contemporary Drug Synthesis

The document "Contemporary Drug Synthesis" from 2004 provided an overview of various pharmaceutical compounds and their synthesis, covering a range of therapeutic areas. It included discussions on antithrombotics like Ticlopidine and Clopidogrel, COX-2 inhibitors such as Celecoxib and Rofecoxib, and H+/K+ -ATPase inhibitors like Esomeprazole. It also addressed protein-tyrosine kinase inhibitors, non-sedating antihistamines, and cosmeceuticals, including Minoxidil and Finasteride, which were relevant to hair growth and hair loss treatment. Other topics included antibacterials, atypical antipsychotics, statins, antidepressants, anti-obesity drugs, triptans for migraines, PDE 5 inhibitors for erectile dysfunction, and antiasthmatics. The document served as a comprehensive guide to the synthesis of these contemporary drugs at the time.